Company Filing History:
Years Active: 2000-2002
Title: The Innovations of John Paul Oberdier
Introduction
John Paul Oberdier is an accomplished inventor based in Gurnee, IL (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing stable formulations that enhance the efficacy of therapeutic agents.
Latest Patents
Oberdier's latest patents include innovative cosolvent formulations that disclose stable pharmaceutical formulations of a therapeutic agent, a low molecular weight alcohol, and a glycol derivative. One of the preferred formulations includes 19-nor-1α,3β,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene. Additionally, he has developed low oxygen content compositions of 1α, 25-dihydroxycholecalciferol, which relate to stable compositions comprising this compound, a unit dose system in a sealed vessel, and a process for preparing them.
Career Highlights
Oberdier is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Lukchiu Li and Edward Anthony Pec, who have collaborated with him on various projects within the pharmaceutical domain.
Conclusion
John Paul Oberdier's contributions to pharmaceutical innovations demonstrate his commitment to advancing healthcare through effective formulations. His patents reflect a deep understanding of the complexities involved in drug development and stability.